Nordic Issuing

Ongoing case

Bioextrax AB

Back to all cases

Bioextrax AB

1 Jun - 15 Jun 2022Warrant exercise TO 2

Bioextrax was founded in 2014 based on research at the Department of Biotechnology at Lund University.

Its process technologies enable cost-effective production of the bioplastic PHA from sucrose (sugar) as a raw material, cost-effective and completely bio-based extraction of PHA from PHA-producing bacteria with a protein hydrolyzate as a by-product, as well as cost-effective production of microfibers from feathers and proteins and amino acids from feathers or slaughterhouse waste. Bioextrax process technologies thus cost-effectively produce a number of different environmentally friendly materials, using cheap raw materials or waste streams / industrial residues as raw materials. The company’s current business model is to offer licenses for the use of its various process technologies in different business areas. The company is listed on the Spotlight Stock Market.

Read more at the company's website

The offer in summary

Subscription period: 1 June - 15 June 2022

Price per share: SEK 19.64

Trading with warrant: 1 June - 13 June 2022

Terms: Holders of one (1) warrants of serie TO 2 have the right to subscribe for one and a third (1 1/3) new share

Payment date: 15 June 2022

Market place: Spotlight Stock Market

Financial advicer: Sedermera Corporate Finance